FDA-approved drugs that may fight HIV identified
August 21st, 2010 - 12:09 pm ICT by ANIWashington, Aug 21 (ANI): University of Minnesota researchers have identified two FDA approved drugs that may fight HIV.
“HIV’s ability to mutate makes it difficult to target and treat,” said molecular virologist Louis Mansky.
“We wanted to take advantage of this behavior by stimulating HIV’s mutation rate, essentially using the virus as a weapon against itself,” Mansky added.
The two drugs, decitabine and gemcitabine - both FDA approved and currently used in pre-cancer and cancer therapy - were found to eliminate HIV infection in the mouse model by causing the virus to mutate itself to death - an outcome researchers dubbed “lethal mutagenesis.”
Mansky and colleague Christine Clouser found that the drug concentrations needed to eliminate HIV infection cause no measurable cell toxicity and were effective against HIV cultures at concentrations well below the current levels used for cancer treatment.
Gemcitabine and decitabine have been administered in pre-clinical trials with mice. Initial findings confirm that the drugs are an effective antiviral therapy for HIV.
The researchers are now in the process of modifying the drugs to forms that can be absorbed by the human body when taken orally.
The findings were recently published online in the Journal of Virology. (ANI)
- Widely used HIV drug could help prevent cervical cancer - May 04, 2011
- First ever pill to beat HIV under FDA consideration - May 10, 2012
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- Flu's secret evolution strategy unveiled - Jun 11, 2010
- New strategy could increase antiviral drugs' effectiveness - Jul 20, 2010
- How 'chameleon-like' HIV virus eludes treatment by mutating - Dec 16, 2010
- New therapy could help beat Hepatitis C virus - Jan 17, 2012
- New find may offer protection against hepatitis C treatment-related anemia - Jan 26, 2011
- Drug cocktail shows promise against hepatitis C - Mar 31, 2011
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- FDA Sanctions New Drug For Prostrate Cancer Treatment - Jun 18, 2010
- Scientists identify molecule that flicks on immune system - May 21, 2012
- Triple-combo drug may treat resistant swine flu - Oct 28, 2009
- New finding could lead to novel HIV treatments - Aug 25, 2010
- How 'silent HIV virus' attacks immune system - Sep 21, 2010
Tags: antiviral therapy, cancer therapy, cancer treatment, clinical trials, clouser, colleague, decitabine, drug concentrations, fda approved drugs, gemcitabine, hiv, hiv infection, human body, initial findings, journal of virology, minnesota researchers, mouse model, mutation rate, treatment gemcitabine, university of minnesota